---
title: "Medicus Pharma Ltd. (MDCX.US)"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/MDCX.US.md"
symbol: "MDCX.US"
name: "Medicus Pharma Ltd."
industry: "Biotechnology"
datetime: "2026-05-21T22:29:43.759Z"
locales:
  - [en](https://longbridge.com/en/quote/MDCX.US.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/MDCX.US.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/MDCX.US.md)
---

# Medicus Pharma Ltd. (MDCX.US)

## Company Overview

Medicus Pharma Ltd., a biotech/life sciences company, focuses on developing clinical development programs of therapeutic assets in the United States. It is developing SKNJCT-003, which is in Phase 2 study for the treatment of basal cell carcinoma of the skin. The company has a strategic collaboration with the Gorlin Syndrome Alliance to access to SKINJECT in Patients with Gorlin Syndrome. The company was formerly known as Interactive Capital Partners Corporation and changed its name to Medicus Pharma Ltd.

| Item | Detail |
|------|--------|
| Industry | Biotechnology |
| Exchange | US Market |
| Website | [medicuspharma.com](https://medicuspharma.com) |

## Key Drivers
> *AI-analyzed key factors driving this stock's performance*


## Longbridge Financial Score™: 
> *Longbridge Financial Score™ — Proprietary multi-factor rating model by Longbridge*
> Updated: 1970-01-01T00:00:00.000Z

**Overall:  (0.00)**

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | -0.22 | 94 | - | - | - |
| PB | 8.61 | 380 | 15.00 | 14.29 | 11.41 |
| Dividend Yield | 0.00% | - | - | - | - |

## Institutional View

### Analyst Rating Distribution

> As of 2026-05-15T04:00:00.000Z

Total Analysts: **4**

| Rating | Count | Percentage |
|--------|-------|-----------| 
| Buy | 3 | 75% |
| Overweight | 1 | 25% |

### Target Price Forecast

| Metric | Price |
|--------|-------|
| Current Price | 0.29 |
| Highest Target | 9.00 |
| Lowest Target | 2.00 |

## References

- [Company Overview — Profile, executives, shareholders, business breakdown](https://longbridge.com/en/quote/MDCX.US/overview.md)
- [Financial Reports — Income, balance sheet, cash flow, dividends](https://longbridge.com/en/quote/MDCX.US/norm.md)
- [Related News](https://longbridge.com/en/quote/MDCX.US/news.md)
- [Filings — Company announcements and regulatory filings](https://longbridge.com/en/quote/MDCX.US/filings.md)

---

> **Disclaimer: This article is for reference only and does not constitute any investment advice.**